Company Filing History:
Years Active: 2017
Title: Kirsten Norrelund: Innovator in Dermatological Treatments
Introduction
Kirsten Norrelund is a prominent inventor based in Ballerup, Denmark. She has made significant contributions to the field of dermatology, particularly in the treatment of actinic keratosis. Her innovative approach has led to the development of a unique method that enhances the efficacy of topical treatments.
Latest Patents
Kirsten holds a patent for the "Method of topically treating actinic keratosis with ingenol mebutate cycle therapy." This invention focuses on the cyclic or repeated use of ingenol mebutate for the topical treatment of actinic keratosis lesions. The method involves a first treatment cycle that applies a topical gel formulated with ingenol mebutate at a specific dosage strength. If the treatment area does not clear or remains affected by AK lesions, a second treatment cycle is initiated using the same gel. This innovative approach also includes spot or individual lesion therapy following the bi-cyclic treatment.
Career Highlights
Kirsten Norrelund has established herself as a key figure in the pharmaceutical industry. She works with Leo Laboratories Limited, where she continues to develop and refine treatments that address skin conditions. Her dedication to improving patient outcomes is evident in her research and development efforts.
Collaborations
Due to space constraints, the details of her collaborations will not be included.
Conclusion
Kirsten Norrelund's contributions to dermatological treatments exemplify her commitment to innovation in healthcare. Her patented method for treating actinic keratosis showcases her expertise and dedication to improving patient care.